Stroke treatment - Light at the end of the tunnel?

Nature Biotechnology

Volumn 25, Issue 8, 2007, Pages 838-840

  Garber, Ken ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DISUFENTON SODIUM; VASCULAR TARGETING AGENT;

BIOTECHNOLOGY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG MANUFACTURE; HEART DISEASE; HUMAN; NEUROPROTECTION; PRIORITY JOURNAL; SHORT SURVEY; UNITED KINGDOM;

CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; DRUG INDUSTRY; HUMANS; INTERNATIONALITY; NEUROPROTECTIVE AGENTS;

EID: 34547799633     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0807-838     Document Type: Short Survey

References (4)

1. Reynolds, B.A. et al. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255, 1707-1710 (1992).
2. Luskin, M.B. Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone. Neuron 11, 173-189 (1993).
3. Lois, C. et al. Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc. Natl. Acad. Sci. USA 90, 2074-2077 (1993).
4. Kolb, B. et al. Growth factor-stimulated generation of new cortical tissue and functional recovery after stroke damage to the motor cortex of rats. J. Cereb. Blood Flow Metab. 27, 983-987 (2006).